RNASEL and prostate carcinoma: Indeed, the prostate cancer LNCaP cell line used herein lacks XMRV-restricting APOBECs [27] and contains a deletion mutation of one allele of RNaseL [28], a gene critical in the innate immune response to retroviruses.